MARKETING AUTHORIZATION OF GENERIC DRUG: GLOBAL ISSUE AND CHALLENGES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2013, Vol 1, Issue 3
Abstract
Generic medicines are those whose patent protection has expired, and which may be produced by manufacturers other than the innovator company. Use of generic medicines has been increasing in recent years, primarily as a cost saving measure in healthcare provision. Generic medicines are typically 20 to 90% cheaper than originator equivalents. The objective is to provide a high-level description of what generic medicines are and how they differ, at a regulatory and legislative level, from originator medicines. It describes the current and historical regulation of medicines in the world’s two main pharmaceutical markets, in addition to the similarities, as well as the differences, between generics and their originator equivalents including the reasons for the cost differences seen between originator and generic medicines. This article refers to the general generic drug approval process in India, USA, and Japan. They have different regulation and approval process.
Authors and Affiliations
Kashyap Pankaj, Duggal Eshant, Budhwar Parveen, Badjatya Jitendra Kumar
Keywords
Related Articles
- EP ID EP338230
- DOI -
- Views 156
- Downloads 0
OVERVIEW OF DRUG REGULATORY AFFAIRS AND REGULATORY PROFESSION
Pharmaceutical drug regulatory affairs govern registration parameters of pharmaceutical products. It has a broad spectrum covering all aspects of documentation and marketing in legalized form. The pharmaceutical industry...
CURRENT REGULATION OF MEDICAL GASES IN INDIA AND FUTURE ASPECTS
Generally medical gases are administered or supplied directly to the patients. They should be manufactured and transferred with the highest quality possible as per standards and limits decided by the different regulatory...
Regulatory requirement for the approval of Generic Drug in Cambodia as per ASEAN Common Technical Dossier (ACTD)
Drug approval process differs from one country to another country. In some countries only single body regulates the drug as well as responsible for all regulatory work which is a challenging task for the pharmaceutical c...
DRUG PRODUCT REGISTRATION IN SEMI-REGULATED MARKET
There found a diversity of regulatory requirement in Semi regulated market. This region consists of mainly the countries from Asia pacific, Latin America, Eastern Europe, Africa and Gulf countries. Countries from Asia pa...
EXCLUSIVITY STRATEGIES OF INNOVATOR DRUG DEVELOPERS
Pharmaceutical drug development had become very costly and time consuming. There is an estimate that a drug from molecular development to marketing approvals cost $800 Millions. Drug approval process is time consuming pr...